ALIADA THERAPEUTICS
Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases. Its platform applies its technology to specific CNS target antibody binders and progress programs through preclinical evaluation to help medical professionals treat CNS diseases. The company was founded in 2021 and is headquartered in Boston, Massachusetts.
ALIADA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2021-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.aliadatx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
32 M USD
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Starfish Neuroscience
Starfish Neuroscience is a company that creates brain interfaces for the treatment of neurological and neuropsychiatric illnesses.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Founder
Official Site Inspections
http://www.aliadatx.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aliada Therapeutics"
Aliada Therapeutics – Beyond boundaries
At the foundation of the Modular Delivery (MODEL) platform are small modular protein domains with optimized developability and stability. Originally designed by Janssen researchers, the …See details»
Aliada Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases. Its platform applies its technology to specific CNS target antibody binders and …See details»
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in …
Oct 28, 2024 For more information visit www.aliadatx.com and follow us on LinkedIn and X. Forward-Looking Statements Some statements in this news release are, or may be …See details»
Aliada Therapeutics - LinkedIn
J. Michael Ryan Chief Medical Officer, Co-Founder @ Aliada Therapeutics | Neuroscience, Clinical Trials, Neurology, PsychiatrySee details»
Aliada Therapeutics Company Profile 2024: Valuation, …
Aliada Therapeutics General Information Description. Developer of drug development therapy designed to treat central nervous system diseases. The company applies its novel technology to specific central nervous system target …See details»
Contact – Aliada Therapeutics
Contact [email protected]. Aliada Therapeutics, Inc. 501 Boylston Street 9 th Floor Boston, MA 02116See details»
Aliada Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 501 Boylston Street 9th Floor. Boston, Massachusetts, 02116, United States. 617-721-0860See details»
Aliada Therapeutics - VentureRadar
Website: https://www.aliadatx.com/ Develops a versatile platform for CNS drug development, expanding across various modalities and applying novel technology to ...See details»
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in …
Oct 28, 2024 For more information visit www.aliadatx.com and follow us on LinkedIn and X. Forward-Looking Statements . Some statements in this news release are, or may be …See details»
Aliada Therapeutics - Overview, News & Similar companies
Www.aliadatx.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. No recent news or media. Overview ; Org Chart ; Who is Aliada …See details»
Programs – Aliada Therapeutics
Aliada’s ALIA-1758 has the potential to be a best-in-class therapy for the treatment of patients with Alzheimer’s disease (AD). MODEL platform-enabled by Aliada to harness transport via …See details»
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in …
Oct 28, 2024 AbbVie (NYSE: ABBV) and Aliada Therapeutics today announced a definitive agreement under which AbbVie will acquire Aliada, a biotechnology company advancing …See details»
Org Chart Aliada Therapeutics - The Official Board
For each of our 1,248,076 listed executives, discover their exact roles and their biographies.See details»
Aliada Therapeutics' financial review - Apollo.io
Biologics are transforming the treatment of numerous diseases, but many CNS diseases remain largely out of reach due to the challenge of crossing the blood-brain barrier and navigating the …See details»
Careers – Aliada Therapeutics
If you are interested in working at Aliada, please submit your resume noting your specific position interest to: [email protected]. Applicants must be authorized to work for ANY employer in …See details»
www.aliadatx.net
Www.aliadatx.netSee details»
Platform – Aliada Therapeutics
The modular structure and stable design of the MODEL platform together create a powerfully versatile system for CNS drug delivery, designed with the ability to take a modality-agnostic …See details»
Press & Publications – Aliada Therapeutics
Oct 28, 2024 Preclinical proof-of-platform for our blood-brain barrier crossing technology’s transformative power is presented in a December 2022 publication from Janssen in Cell Press: …See details»